Latest Breaking News On - Department of gastrointestinal oncology - Page 1 : comparemela.com

Dr Shitara on the Background of the CheckMate 649 Trial in GEJ Adenocarcinoma

Kohei Shitara, MD, discusses the background of the phase 3 CheckMate 649 study in advanced gastric cancer, GEJ cancer, and esophageal adenocarcinoma.

Kohei shitaraNational cancer center hospitalDepartment of gastrointestinal oncologyGastrointestinal oncologyNational cancer center hospital eastClinical oncology

Japan s MHLW Approves Zolbetuximab in CLDN18 2-Positive Gastric Cancer

The Japanese Ministry of Health, Labour and Welfare has approved zolbetuximab for CLDN18.2-positive, unresectable, advanced or recurrent gastric cancer.

Kohei shitaraMoitreyee chatterjee kishoreJapan ministry of healthAstellas pharma incDepartment of gastrointestinal oncologyNational cancer center hospitalOncology development at astellasGastrointestinal oncologyNational cancer center hospital eastRoche diagnosticsRxdx assayImmuno oncology development

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matt scaloTakayuki yoshinoDale muzzeyGlenn farrellDepartment of gastrointestinal oncologyDivision for the promotion of drugGenetics incExchange commissionNational cancer center hospital eastDeputy directorHospital eastDiagnostic developmentGastrointestinal oncologyChief scientific officerPrivate securities litigation reform actAnnual report

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies.

United statesKohei shitaraValerie malyvanh jansenNational cancer center hospitalDepartment of gastrointestinal oncologyPrnewswire elevation oncology incCorporate communications investor relationsElevation oncology incExchange commissionChief medical officerGastrointestinal oncologyNational cancer center hospital eastElevation oncologyPrivate securities litigation reform actOncology investorCorporate communications

Elevation Oncology (ELEV) Expands Ongoing Phase 1 Clinical Trial of EO-3021

Elevation Oncology (ELEV) Expands Ongoing Phase 1 Clinical Trial of EO-3021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesValerie malyvanh jansenKohei shitaraElevation oncology incDepartment of gastrointestinal oncologyNational cancer center hospitalElevation oncologyMalyvanh jansenChief medical officerGastrointestinal oncologyNational cancer center hospital east